Inventor profile of:

Andreas Muhs

City:

Cugy

Country:

Switzerland

Published Applications:

33

Last publication date:

2025-09-04

Top Assignees for applications by Andreas Muhs

The entities that hold a legal rights for patent applications filed by inventor Muhs Andreas:

Recent patent applications by Muhs Andreas

Andreas Muhs from Cugy, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-04
US20250275920A1
Human necessities

Method of Safe Administration of Phosphorylated TAU Peptide Vaccine

#2 | 2025-05-08
US20250144212A1
Human necessities

LIPOSOMES CONTAINING PHOSPHORYLATED TAU PEPTIDES FOR INDUCING SUSTAINED IMMUNE RESPONSES

#3 | 2025-05-01
US20250134973A1
Human necessities

Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune Responses

#4 | 2024-08-15
US20240270829A1
Chemistry; metallurgy

Vaccine Therapy

#5 | 2023-11-30
US20230381108A1
Human necessities

Method of Safe Administration of Phosphorylated TAU Peptide Vaccine

#6 | 2023-10-26
US20230338535A1
Human necessities

Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune Responses

#7 | 2023-08-17
US20230257433A1
Chemistry; metallurgy

Heterologous Administration of Tau Vaccines

#8 | 2022-07-21
US20220227847A1
Chemistry; metallurgy

HUMANIZED ANTIBODY

#9 | 2021-10-14
US20210317197A1
Chemistry; metallurgy

HUMANIZED ANTIBODY

#10 | 2021-05-13
US20210139572A1
Chemistry; metallurgy

Anti-tau antibodies and methods of use

#11 | 2020-12-03
US20200376078A1
Human necessities

Compositions of phosphorylated tau peptides and uses thereof

#12 | 2020-10-29
US20200339643A1
Chemistry; metallurgy

Heterologous administration of tau vaccines

#13 | 2020-08-13
US20200253873A1
Human necessities

Method of safe administration of phosphorylated tau peptide vaccine

#14 | 2020-02-20
US20200055928A1
Chemistry; metallurgy

HUMANIZED ANTIBODY

#15 | 2019-12-05
US20190367592A1
Chemistry; metallurgy

Anti-Tau antibodies and methods of use

#16 | 2019-04-25
US20190119341A1
Chemistry; metallurgy

Compositions of phosphorylated tau peptides and uses thereof

#17 | 2019-01-31
US20190031746A1
Chemistry; metallurgy

HUMANIZED ANTIBODY IGG1

#18 | 2018-11-15
US20180327485A1
Chemistry; metallurgy

HUMANIZED ANTIBODY

#19 | 2016-09-22
US20160272699A1
Chemistry; metallurgy

HUMANIZED ANTIBODY

#20 | 2016-08-25
US20160244514A1
Chemistry; metallurgy

Humanized Antibody

#21 | 2016-06-16
US20160168234A1
Chemistry; metallurgy

HUMANIZED ANTIBODY IGG1

#22 | 2016-01-28
US20160024193A1
Chemistry; metallurgy

Anti-tau antibodies and methods of use

#23 | 2016-01-07
US20160000910A1
Human necessities

Polynucleotides encoding anti-amyloid beta monoclonal antibodies

#24 | 2015-09-17
US20150259406A1
Chemistry; metallurgy

Pharmaceutical Composition of an Antigenic Tau Peptide Reconstituted in a Liposome and Related Antibodies and Cell Lines

#25 | 2015-06-25
US20150175682A1
Chemistry; metallurgy

Humanized tau antibody

#26 | 2015-01-22
US20150023950A1
Chemistry; metallurgy

2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system

#27 | 2014-10-23
US20140314837A1
Human necessities

Vaccine Therapy

#28 | 2014-09-11
US20140255412A1
Chemistry; metallurgy

Pharmaceutical Composition of an Antigenic Tau Peptide Reconstituted in a Liposome and Related Antibodies and Cell Lines

#29 | 2014-07-17
US20140199323A1
Chemistry; metallurgy

Monoclonal antibody

#30 | 2013-10-31
US20130287838A1
Human necessities

Vaccine engineering

#31 | 2013-08-29
US20130224287A1
Human necessities

Method for preparing liposome-based constructs

#32 | 2012-07-05
US20120171216A1
Physics

Polynucleotides encoding an anti-beta-amyloid monoclonal antibody

#33 | 2010-11-18
US20100291097A1
Chemistry; metallurgy

Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibody

InventorID:

413949 ⎘